Journal of Atrial Fibrillation

Cardiofront Logo
Jafib Logo
St. Jude Medical

May 24th, 2013
Submit Manuscript
AF Literature Database
Search Knowledgebase by
Author Last name starts with
Asirvatham Samuel J SJ(3)Ayman A. Hussein, MD(3)Botto GL(2)
Badger Troy J TJ(2)Casella M(2)Blanke Philipp P(2)
Anné Wim W(2)Berenfeld Omer O(2)Chen Peng-Sheng PS(2)
Albert Nancy M NM(2)Cook G Elliott GE(2)Chamberlain AM(2)
Bokeriia L A LA(2)Caputo M(2)Chao TF(2)
Andrade JG(2)Ajay K Jain(2)Coronel Ruben R(1)
Albers Gregory W GW(1)Cappato Riccardo R(1)Bugnicourt Jean-Marc JM(1)
Amin AS(1)Andreou Andreas Yiangou AY(1)Boccuzzi Stephen J SJ(1)
Bolderman Robert W RW(1)Chang Jen-Ping JP(1)Bouzas-Mosquera Alberto A(1)
Choi Jong-Il JI(1)Candeias Rui R(1)Callanan Deborah D(1)
Calvo Naiara N(1)Brown Aaron Michael AM(1)Cairns JA(1)
Alf Inge Larsen(1)Anousheh Ramtin R(1)Bellamy L L(1)
Canabal Berlanga A A(1)Abe Hidetoshi H(1)Bhindi Ravinay R(1)
Cordero Alberto A(1)Baker William L WL(1)Bockeria Leo L(1)
Capranzano Piera P(1)Brooks Anthony G AG(1)Adam Oliver O(1)
Berg Jenny J(1)Brevoord D(1)Aliyev Farid F(1)
Bai Mei M(1)Cerillo Alfredo Giuseppe AG(1)
Literature Related to Jonas Oldgren, MD [Author]
[1]
[Still strong reason for enthusiasm for a new stroke-preventing drug]
Authors : Oldgren Jonas J;
Affiliation : Uppsala kliniska forskningscentrum (UCR), Akademiska sjukhuset och Uppsala universitet. Jonas.Oldgren@ucr.uu.se
Journal : Lakartidningen   ()
Related Links: Pubmed | Publisher website N/A
Dronedarone is superior to placebo the case for optimism.
Authors : Cooper Jonas A JA;
Affiliation : N/A
Journal : J. Am. Coll. Cardiol.   (2010)
Related Links: Pubmed | Publisher website
Abnormal P-wave morphology is a predictor of atrial fibrillation development and cardiac death in MADIT II patients.
Authors : Holmqvist Fredrik F; Platonov Pyotr G PG; McNitt Scott S; Polonsky Slava S; Carlson Jonas J; Zareba Wojciech W; Moss Arthur J AJ; ;
Affiliation : Department of Cardiology, Lund University Hospital, SE-221 85 Lund, Sweden. fredrik.holmqvist@med.lu.se
Journal : Ann Noninvasive Electrocardiol   (2010)
Related Links: Pubmed | Publisher website
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
Authors : John W. Eikelboom, MBBS; Lars Wallentin, MD; Stuart J. Connolly, MD; Mike Ezekowitz, MD; Jeff S. Healey, MD; Jonas Oldgren, MD; Sean Yang, BComSc; Marco Alings, MD; Scott Kaatz, DO; Stefan H. Hohnloser, MD; Hans-Christoph Diener, MD; Maria Grazia Franzosi, PhD; Kurt Huber, MD; Paul Reilly, MD; Jeanne Varrone, MD;
Affiliation : Correspondence to John Eikelboom, MBBS, Population Health Research Institute, 237 Barton St E, Hamilton, Ontario, Canada L8L 2X2. E-mail eikelbj@mcmaster.ca
Journal : Circulation   (2011)
Related Links: Pubmed | Publisher website
Dabigatran Versus Warfarin in Patients With Atrial Fibrillation
Authors : Rangadham Nagarakanti, MD; Michael D. Ezekowitz, MBChB, DPhil, FRCP, FACC; Jonas Oldgren, MD, PhD; Sean Yang, MSc; Michael Chernick, PhD; Timothy H. Aikens, BA; Greg Flaker, MD; Josep Brugada, MD; Gabriel Kamenský, MD, PhD, FESC; Amit Parekh, MD; Paul A. Reilly, PhD; Salim Yusuf, FRCPC, DPhil;
Affiliation : Correspondence to Michael D. Ezekowitz, MBChB, DPhil, FRCP, Lankenau Institute for Medical Research, 100 Lancaster Ave, Ste G36, Wynnewood, PA 19096. E-mail ezekowitzm@mlhs.org
Journal : Circulation   (2011)
Related Links: Pubmed | Publisher website
Dabigatran Versus Warfarin in Patients With Atrial Fibrillation
Authors : Rangadham Nagarakanti, MD; Michael D. Ezekowitz, MBChB, DPhil, FRCP, FACC; Jonas Oldgren, MD, PhD; Sean Yang, MSc; Michael Chernick, PhD; Timothy H. Aikens, BA; Greg Flaker, MD; Josep Brugada, MD; Gabriel Kamenský, MD, PhD, FESC; Amit Parekh, MD; Paul A. Reilly, PhD; Salim Yusuf, FRCPC, DPhil;
Affiliation : Correspondence to Michael D. Ezekowitz, MBChB, DPhil, FRCP, Lankenau Institute for Medical Research, 100 Lancaster Ave, Ste G36, Wynnewood, PA 19096. E-mail ezekowitzm@mlhs.org
Journal : Circulation   (2011)
Related Links: Pubmed | Publisher website
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
Authors : John W. Eikelboom, MBBS; Lars Wallentin, MD; Stuart J. Connolly, MD; Mike Ezekowitz, MD; Jeff S. Healey, MD; Jonas Oldgren, MD; Sean Yang, BComSc; Marco Alings, MD; Scott Kaatz, DO; Stefan H. Hohnloser, MD; Hans-Christoph Diener, MD; Maria Grazia Franzosi, PhD; Kurt Huber, MD; Paul Reilly, MD; Jeanne Varrone, MD;
Affiliation : Correspondence to John Eikelboom, MBBS, Population Health Research Institute, 237 Barton St E, Hamilton, Ontario, Canada L8L 2X2. E-mail eikelbj@mcmaster.ca
Journal : N/A   (2011)
Related Links: Pubmed | Publisher website
Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial.
Authors : Eikelboom JW; Wallentin L; Connolly SJ; Ezekowitz M; Healey JS; Oldgren J; Yang S; Alings M; Kaatz S; Hohnloser SH; Diener HC; Franzosi MG; Huber K; Reilly P; Varrone J;
Affiliation : Correspondence to John Eikelboom, MBBS, Population Health Research Institute, 237 Barton St E, Hamilton, Ontario, Canada L8L 2X2. E-mail eikelbj@mcmaster.ca
Journal : Circulation   (2011)
Related Links: Pubmed | Publisher website
"Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation A Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Substudy
Authors : Jonas Oldgren, MD, PhD; Ulrika Andersson, MSc; Stuart J. Connolly, MD; Michael D. Ezekowitz, MB, ChB; Stefan H. Hohnloser, MD; Paul A. Reilly, PhD; Dragos Vinereanu, MD, PhD; Agneta Siegbahn, MD, PhD; Salim Yusuf, MD, PhD;
Affiliation : " Correspondence to Ziad Hijazi, MD, Uppsala Clinical Research Center, Dag Hammarskjölds väg 14B, 1st floor, SE- 752 37 Uppsala, Sweden. E-mail Ziad.hijazi@ucr.uu.se "
Journal : Original Articles   (2012)
Related Links: Pubmed | Publisher website
Myocardial Ischemic Events in Patients With Atrial Fibrillation Treated With Dabigatran or Warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial
Authors : Hohnloser, MD; Jonas Oldgren, MD; Sean Yang, PhD; Lars Wallentin, MD; Michael Ezekowitz, MD; Paul Reilly, MD; John Eikelboom, MD; Martina Brueckmann, MD; Salim Yusuf, MD;
Affiliation : Correspondence to Stefan H. Hohnloser, MD, FACC, FESC, FHRS, Division of Clinical Electrophysiology, J.W. Goethe University Hospital, Theodor-Stern-Kai 7, D 60590 Frankfurt, Germany. E-mail Hohnloser@em.uni-frankfurt.de
Journal : Original Articles   (2012)
Related Links: Pubmed | Publisher website

ISLAA Videos

 ISLAA Videos
1st International Symposium on Left Atrial Appendage

Upcoming Events

KANSAS CITY HEART RHYTHM SYMPOSIUM (KCHRS) 2011
KANSAS CITY HEART RHYTHM SYMPOSIUM (KCHRS) 2013
Venice Arrhythmias
VENICE ARRHYTHMIAS 2013

Ablation Specialist

Jafib
Powered by - Jafib Team   Privacy Policy | Site Map
hits counter